{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-112728","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.387017+00:00","generated_at":"2026-05-16T18:24:43.728029+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vyome reports Q3 cash $5.7M; VT-1953 Phase 2 interim hits primary endpoint","bullets":["VT-1953 Phase 2 interim data: statistically significant malodor reduction (p<0.001); pain and QoL improved; safety profile excellent.","Cash, equivalents & short-term investments $5.7 million; expected runway through end of 2026 inclusive of clinical trials.","Net loss primarily from one-time merger/financing non-cash charges; company is pre-revenue clinical stage.","Clean capital structure: 5,556,295 shares outstanding, no preferred stock, no warrants or convertible notes.","Acquired MIT startup Oculo to launch AI strategy; hired new CTO and SVP of Clinical Development with Big Pharma backgrounds."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-112728","json":"https://secwatch.observer/filing/0001213900-25-112728.json","markdown":"https://secwatch.observer/filing/0001213900-25-112728.md","text":"https://secwatch.observer/filing/0001213900-25-112728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000121390025112728/0001213900-25-112728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000121390025112728/ea0266347-8k_vyome.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:24:43.728029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}